Use of microbiome analysis as a complementary endpoint in clinical trials
- DOI
- 10.1016/j.isci.2025.113754
- Published
- 2025-11
- Container
- iScience
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.isci.2025.113754,
title = {Use of microbiome analysis as a complementary endpoint in clinical trials},
author = {Lourdes Velo-Suarez and Charles-Antoine Guilloux and Rozenn Le Berre and Stéphanie Gouriou and Gilles Rault and Dominique Mottier and Laurent Meijer and Geneviève Héry-Arnaud},
year = {2025},
journal = {iScience},
doi = {10.1016/j.isci.2025.113754},
url = {https://doi.org/10.1016/j.isci.2025.113754}
}RIS
TY - JOUR TI - Use of microbiome analysis as a complementary endpoint in clinical trials AU - Lourdes Velo-Suarez AU - Charles-Antoine Guilloux AU - Rozenn Le Berre AU - Stéphanie Gouriou AU - Gilles Rault AU - Dominique Mottier AU - Laurent Meijer AU - Geneviève Héry-Arnaud PY - 2025 JO - iScience DO - 10.1016/j.isci.2025.113754 UR - https://doi.org/10.1016/j.isci.2025.113754 ER -
APA
Velo-Suarez, L., Guilloux, C., Berre, R. L., Gouriou, S., Rault, G., Mottier, D., Meijer, L., & Héry-Arnaud, G. (2025). Use of microbiome analysis as a complementary endpoint in clinical trials. iScience. https://doi.org/10.1016/j.isci.2025.113754
Source records
- crossref · retrieved 2026-09-27T04:02:33.831Z